Protecting the Gut: A Novel Therapeutic Avenue for Reducing the Damaging Consequences of Obesity

Grant number: 105717 | Funding period: 2021 - 2026

Active

Abstract

Most patients with obesity develop gut dysfunction. Symptoms including constipation and diarrhoea often present before other common comorbidities like diabetes and heart disease, suggesting that early pathology in obesity may begin in the gut. This research project aims to understand the mechanisms through which gut dysfunction develops in obese mice and human patients, and test a clinically approved compound that has demonstrated gut protective properties for the first time in obesity.

Related publications (5)

University of Melbourne Researchers